How much is the Epigenetics Market market?

The epigenetics market market size is estimated to grow at $$ 1477.78 mn in 2023. Read More

What is the growth rate of the Epigenetics Market market?

The growth rate of the epigenetics market year-over-year is 14.75%. Read More

Which region held the largest market share in the Epigenetics Market market?

North America is the region to held the largest market share with 39% growth. Read More

Who are the key players in the Epigenetics Market market?

Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Eisai Co. Ltd., Element Biosciences Inc, EpiGentek Group Inc., Eurofins .... Read More

Which Segment has the largest market share in the Epigenetics Market market?

Application is the segment that has the largest market share in the market. Read More

Epigenetics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Feb 2024
Pages: 163
SKU: IRTNTR75055

Enjoy complimentary customisation on priority with our Enterprise License!

Epigenetics Market Size 2024-2028

The epigenetics market size is forecast to increase by USD 1.48 billion at a CAGR of 14.75% between 2023 and 2028. The market is experiencing significant growth, driven by the rising applications of epigenetics in non-oncology diseases. Epigenetics, the study of heritable changes in gene expression without alteration of the genetic code, is increasingly being explored for its potential in various therapeutic areas, including neurology, interventional cardiology, and metabolic disorders. Technological advances in the life sciences industry are also fueling market growth, with innovations in DNA sequencing and editing technologies enabling more accurate and efficient epigenetic analysis. However, the lack of clinical validation on direct-to-consumer genetic tests poses a challenge to market growth, as the reliability and accuracy of these tests remain a concern for both healthcare providers and consumers. Despite this, the market is expected to continue its upward trajectory, driven by the potential of epigenetics to revolutionize personalized medicine and improve patient outcomes.

What will be the Size of the Epigenetics Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global epigenetics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global epigenetics market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Oncology - Market size and forecast 2023-2028
- Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)

6.4 Non-oncology - Market size and forecast 2023-2028
- Exhibit 38: Chart on Non-oncology - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Non-oncology - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Non-oncology - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Non-oncology - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Application
- Exhibit 42: Market opportunity by Application ($ million)
- Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Product - Market share 2023-2028 (%)

7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product

7.3 Reagents - Market size and forecast 2023-2028
- Exhibit 48: Chart on Reagents - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Reagents - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Reagents - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Reagents - Year-over-year growth 2023-2028 (%)

7.4 Kits - Market size and forecast 2023-2028
- Exhibit 52: Chart on Kits - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Kits - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Kits - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Kits - Year-over-year growth 2023-2028 (%)

7.5 Enzymes and others - Market size and forecast 2023-2028
- Exhibit 56: Chart on Enzymes and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Enzymes and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Enzymes and others - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Enzymes and others - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Product
- Exhibit 60: Market opportunity by Product ($ million)
- Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Abcam plc
- Exhibit 111: Abcam plc - Overview
- Exhibit 112: Abcam plc - Product / Service
- Exhibit 113: Abcam plc - Key news
- Exhibit 114: Abcam plc - Key offerings

12.4 Active Motif Inc.
- Exhibit 115: Active Motif Inc. - Overview
- Exhibit 116: Active Motif Inc. - Product / Service
- Exhibit 117: Active Motif Inc. - Key offerings

12.5 Agilent Technologies Inc.
- Exhibit 118: Agilent Technologies Inc. - Overview
- Exhibit 119: Agilent Technologies Inc. - Business segments
- Exhibit 120: Agilent Technologies Inc. - Key offerings
- Exhibit 121: Agilent Technologies Inc. - Segment focus

12.6 Bio Rad Laboratories Inc.
- Exhibit 122: Bio Rad Laboratories Inc. - Overview
- Exhibit 123: Bio Rad Laboratories Inc. - Business segments
- Exhibit 124: Bio Rad Laboratories Inc. - Key news
- Exhibit 125: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 126: Bio Rad Laboratories Inc. - Segment focus

12.7 Eisai Co. Ltd.
- Exhibit 127: Eisai Co. Ltd. - Overview
- Exhibit 128: Eisai Co. Ltd. - Business segments
- Exhibit 129: Eisai Co. Ltd. - Key offerings
- Exhibit 130: Eisai Co. Ltd. - Segment focus

12.8 EpiGentek Group Inc.
- Exhibit 131: EpiGentek Group Inc. - Overview
- Exhibit 132: EpiGentek Group Inc. - Product / Service
- Exhibit 133: EpiGentek Group Inc. - Key offerings

12.9 F. Hoffmann La Roche Ltd.
- Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus

12.10 Illumina Inc.
- Exhibit 139: Illumina Inc. - Overview
- Exhibit 140: Illumina Inc. - Business segments
- Exhibit 141: Illumina Inc. - Key news
- Exhibit 142: Illumina Inc. - Key offerings
- Exhibit 143: Illumina Inc. - Segment focus

12.11 Merck KGaA
- Exhibit 144: Merck KGaA - Overview
- Exhibit 145: Merck KGaA - Business segments
- Exhibit 146: Merck KGaA - Key news
- Exhibit 147: Merck KGaA - Key offerings
- Exhibit 148: Merck KGaA - Segment focus

12.12 New England Biolabs Inc.
- Exhibit 149: New England Biolabs Inc. - Overview
- Exhibit 150: New England Biolabs Inc. - Product / Service
- Exhibit 151: New England Biolabs Inc. - Key news
- Exhibit 152: New England Biolabs Inc. - Key offerings

12.13 Pacific Biosciences of California Inc.
- Exhibit 153: Pacific Biosciences of California Inc. - Overview
- Exhibit 154: Pacific Biosciences of California Inc. - Product / Service
- Exhibit 155: Pacific Biosciences of California Inc. - Key offerings

12.14 PerkinElmer Inc
- Exhibit 156: PerkinElmer Inc - Overview
- Exhibit 157: PerkinElmer Inc - Business segments
- Exhibit 158: PerkinElmer Inc - Key news
- Exhibit 159: PerkinElmer Inc - Key offerings
- Exhibit 160: PerkinElmer Inc - Segment focus

12.15 QIAGEN NV
- Exhibit 161: QIAGEN NV - Overview
- Exhibit 162: QIAGEN NV - Product / Service
- Exhibit 163: QIAGEN NV - Key news
- Exhibit 164: QIAGEN NV - Key offerings

12.16 Thermo Fisher Scientific Inc.
- Exhibit 165: Thermo Fisher Scientific Inc. - Overview
- Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 167: Thermo Fisher Scientific Inc. - Key news
- Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

12.17 Zymo Research Corp.
- Exhibit 170: Zymo Research Corp. - Overview
- Exhibit 171: Zymo Research Corp. - Product / Service
- Exhibit 172: Zymo Research Corp. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 173: Inclusions checklist
- Exhibit 174: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 175: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 176: Research methodology
- Exhibit 177: Validation techniques employed for market sizing
- Exhibit 178: Information sources